Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: Emerging organoid models: leaping forward in cancer research

Fig. 1

Cancer organoids can be derived from patients with diverse cancer grades and subtypes. Patient-derived organoids can possess patient-specific genetic and epigenetic contexts for preclinical cancer research and theranostics. Meanwhile, normal organoids can be used to model cancer evolution after the introduction of oncogenic mutations. By using the time-lapse microscopic imaging, tumor cell behaviors can be monitored in real-time. Similar to cell lines, cancer organoid lines can be expanded and cryopreserved to establish a living organoid biobank

Back to article page